Crestor and Bursitis infective - a phase IV clinical study of FDA data

Summary:

Bursitis infective is reported as a side effect among people who take Crestor (rosuvastatin calcium), especially for people who are female, 60+ old, also take Calcium, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Bursitis infective when taking Crestor. It is created by eHealthMe based on reports of 143,349 people who have side effects when taking Crestor from the FDA, and is updated regularly.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,761 Crestor users. Check the latest studies of Crestor.

What is Bursitis infective?

Bursitis infective (the bursa can become infected, this is called infected bursitis) is found to be associated with 119 drugs and 161 conditions by eHealthMe. Check the latest studies of Bursitis infective.

On Jul, 12, 2026

143,349 people reported to have side effects when taking Crestor.
Among them, 30 people (0.02%) have Bursitis infective.

Among these 30 people:

What is the gender of people who have Bursitis infective when taking Crestor? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Bursitis infective when taking Crestor? *

What are other drugs people take besides Crestor? *

What are other side effects people have besides Bursitis infective? *

Localised Infection (infection at the single location): 26 people, 86.67%
Pneumonia: 26 people, 86.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 26 people, 86.67%
Staphylococcal Infection (an infection with staphylococcus bacteria): 26 people, 86.67%
Skin Ulcer: 26 people, 86.67%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 26 people, 86.67%
Infection: 25 people, 83.33%
Osteoporosis (bones weak and more likely to break): 24 people, 80.00%
Peripheral Vascular Disorder: 24 people, 80.00%
Crying: 22 people, 73.33%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 26 people, 86.67%
Pain: 11 people, 36.67%
Diabetes: 11 people, 36.67%
Abdominal Pain Upper: 6 people, 20.00%
Phantom Pain: 4 people, 13.33%
Prostate Cancer Metastatic: 2 people, 6.67%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 2 people, 6.67%
Renal Cell Carcinoma (a kidney cancer): 1 person, 3.33%
Gastric Ulcer (stomach ulcer): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Crestor and have Bursitis infective?

- Check whether Bursitis infective is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Crestor:

Crestor (149,761 reports)

Browse all side effects of Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bursitis infective:

Bursitis infective (119 drugs)

Browse all the conditions that are associated with Bursitis infective:

Bursitis infective (161 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Crestor) and Crestor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.